Another week of breakthrough events is released by DOH, with vaxed events continuing to dominate.
Read More
On and on it goes, and so do the research summaries.
Read More
Another look at the week-over-week analysis shows uncertainty over direction of epidemic.
Read More
The epidemic winds own with a very low rate of actual case detection, but also a very low rate of any serious disease. Let's let it go.
Read More
The latest in the regular series showing the age distribution of all events during the epidemic.
Read More
The final age group, everyone over age 65, where boosters show continuing benefit.
Read More
On to the middle aged group for our breakthrough event analysis.
Read More
On to the 118 to 49 age group, where there appears to be some remaining benefit of vax in preventing hospitalization.
Read More
The next age group for the detailed breakthrough analysis is the 12-17 year-olds.
Read More